Defining the role of histone deacetylases in the inhibition of mammary carcinogenesis by dietary energy restriction (DER): effects of suberoylanilide hydroxamic acid (SAHA) and DER in a rat model
- PMID: 23365133
- PMCID: PMC4636215
- DOI: 10.1158/1940-6207.CAPR-12-0449-T
Defining the role of histone deacetylases in the inhibition of mammary carcinogenesis by dietary energy restriction (DER): effects of suberoylanilide hydroxamic acid (SAHA) and DER in a rat model
Abstract
Dietary energy restriction (DER) inhibits experimentally induced mammary cancer, an effect accompanied by elevated levels of silent information regulator 2 (SIRT1), a class III histone deacetylase (HDAC). However, the effect of DER on targets of other classes of HDACs has not been reported, a highly relevant issue given evidence that HDAC induction favors the development of cancer and tumor growth. Experiments were carried out to determine whether suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor with broad activity, would affect the anti-cancer activity of DER. Female Sprague Dawley rats (n = 30/group) were injected with 1-methyl-1-nitrosourea (50 mg/kg) at 21 days of age and 7 days thereafter were randomized to groups fed: (i) control diet (AIN-93G), (ii) 0.1% SAHA (w/w), (iii) 40% DER, or (iv) 0.1% SAHA + 40% DER. An additional group was fed 0.1% SAHA + 40%DER for 5 weeks and released to control diet for 3 weeks. DER significantly reduced mammary cancer incidence, multiplicity, and cancer burden and prolonged cancer latency (P < 0.01). Cancer inhibition was maintained in SAHA + DER, despite evidence that histone (H2A(Lys9), H2B(Lys5), and H4(Lys5/8/12/16), but not H3(Lys9); P < 0.001) and non-histone protein deacetylation (p53(Lys373) and p53(Lys382); P < 0.001) induced by DER was reversed by SAHA. This indicates that the inhibition of DER of cancer is not dependent on HDAC induction. After releasing rats from DER + SAHA, cancer multiplicity remained lower than control (P < 0.05), consistent with apoptosis-mediated cell deletion. These findings support further investigation of the hypothesis that HDAC induction by DER blunts its anti-carcinogenic impact.
Conflict of interest statement
Figures
Similar articles
-
Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.Anticancer Res. 2002 May-Jun;22(3):1497-504. Anticancer Res. 2002. PMID: 12168829
-
In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).J Med Chem. 2011 Aug 11;54(15):5576-82. doi: 10.1021/jm200620f. Epub 2011 Jul 18. J Med Chem. 2011. PMID: 21721525 Free PMC article.
-
Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.Oncotarget. 2017 Mar 14;8(11):17726-17737. doi: 10.18632/oncotarget.14628. Oncotarget. 2017. PMID: 28099148 Free PMC article.
-
Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.Int J Biochem Cell Biol. 2009 Apr;41(4):736-9. doi: 10.1016/j.biocel.2008.05.026. Epub 2008 Aug 3. Int J Biochem Cell Biol. 2009. PMID: 18725319 Review.
-
[Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].Biol Aujourdhui. 2017;211(1):83-91. doi: 10.1051/jbio/2017014. Epub 2017 Jul 6. Biol Aujourdhui. 2017. PMID: 28682229 Review. French.
Cited by
-
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphoma.Oncotarget. 2014 Jan 15;5(1):95-102. doi: 10.18632/oncotarget.1468. Oncotarget. 2014. PMID: 24395633 Free PMC article.
-
Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives.Front Pharmacol. 2022 Nov 28;13:1035171. doi: 10.3389/fphar.2022.1035171. eCollection 2022. Front Pharmacol. 2022. PMID: 36518665 Free PMC article. Review.
-
Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.Int J Clin Exp Pathol. 2015 Oct 1;8(10):13241-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722524 Free PMC article.
-
Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8732-9. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674239 Free PMC article.
-
Cell Signaling Pathways in Mammary Carcinoma Induced in Rats with Low versus High Inherent Aerobic Capacity.Int J Mol Sci. 2019 Mar 26;20(6):1506. doi: 10.3390/ijms20061506. Int J Mol Sci. 2019. PMID: 30917509 Free PMC article.
References
-
- Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010;31:83–9. - PubMed
-
- Thompson HJ, Jiang W, Zhu Z. Energetics and Cancer: Exploring a Road Less Traveled. In: McTiernan A, editor. Physical Activity, Dietary Calorie Restriction, and Cancer. 1. Springer Science + Business Media, LLC; 2011. pp. 55–67.
-
- International Agency for Research on Cancer. Physical Activity, Weight Control, and Cancer. [8] Lyon: IARC Press; 2002.
- Vainio H, Bianchin IF. Cancer Prevention Handbook.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous